Finance

Lists
VAISHALI:NSE
Vaishali Pharma Ltd
₹7,88
-1,25%
(-0,100) 1D
14 Okt., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for VAISHALI...
Open
₹8,33
High
₹8,33
Low
₹7,86
Mkt. cap
1,06 mjd
Avg. vol.
164,80 k
Volume
83,37 k
P/E ratio
10,87
52-wk high
₹11,15
52-wk low
₹4,75
EPS
₹0,72
No. of employees
30
Open
₹8,33
High
₹8,33
Low
₹7,86
Mkt. cap
1,06 mjd
Avg. vol.
164,80 k
Volume
83,37 k
P/E ratio
10,87
52-wk high
₹11,15
52-wk low
₹4,75
EPS
₹0,72
No. of employees
30
News stories
From web sources and news partners
About Vaishali Pharma Ltd
CEO-
Employees30
Founded1989
Headquarters-
SectorPharmaceutical industry
Websitevaishalipharma.com
Last report
14 Aug. 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
228,91 m / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
334,46 m
246,52 m
269,27 m
228,91 m
Cost of goods sold
296,97 m
209,37 m
245,34 m
194,41 m
Cost of revenue
296,97 m
209,37 m
245,34 m
194,41 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,32 m
7,22 m
11,39 m
7,18 m
Operating expense
25,32 m
22,82 m
27,55 m
21,02 m
Total operating expenses
322,28 m
232,19 m
272,89 m
215,43 m
Operating income
12,18 m
14,33 m
-3,62 m
13,49 m
Other non operating income
8,39 m
8,92 m
-20,98 m
5,80 m
EBT including unusual items
16,58 m
18,33 m
2,94 m
17,89 m
EBT excluding unusual items
16,58 m
18,33 m
2,94 m
17,89 m
Income tax expense
4,72 m
5,15 m
-870,00 k
2,42 m
Effective tax rate
28,44%
28,09%
-29,57%
13,56%
Other operating expenses
17,28 m
14,33 m
-6,49 m
12,48 m
Net income
11,86 m
13,18 m
3,81 m
15,46 m
Net profit margin
3,55%
5,35%
1,42%
6,75%
Earnings per share
-
-
-
-
Interest and investment income
-
-
29,18 m
-
Interest expense
-4,01 m
-5,08 m
-7,21 m
-1,96 m
Net interest expenses
-4,01 m
-5,08 m
21,97 m
-1,96 m
Depreciation and amortization charges
1,72 m
1,27 m
1,59 m
1,37 m
EBITDA
12,79 m
14,94 m
-2,77 m
14,85 m
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme